Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

BRWD3 anticorps (AA 1701-1802) (Cy7)

BRWD3 Reactivité: Humain WB, IF (cc), IF (p) Hôte: Lapin Polyclonal Cy7
N° du produit ABIN1411356
  • Antigène Voir toutes BRWD3 Anticorps
    BRWD3 (Bromodomain and WD Repeat Domain Containing 3 (BRWD3))
    Épitope
    • 14
    • 3
    • 1
    • 1
    AA 1701-1802
    Reactivité
    • 18
    • 3
    • 1
    Humain
    Hôte
    • 18
    Lapin
    Clonalité
    • 18
    Polyclonal
    Conjugué
    • 5
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp BRWD3 est conjugé à/à la Cy7
    Application
    • 18
    • 12
    • 12
    • 7
    • 4
    • 3
    • 3
    • 2
    • 1
    Western Blotting (WB), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))
    Homologie
    Human,Mouse,Rat,Dog,Cow,Sheep,Pig,Horse,Chicken
    Purification
    Purified by Protein A.
    Immunogène
    KLH conjugated synthetic peptide derived from human BRWD3
    Isotype
    IgG
    Top Product
    Discover our top product BRWD3 Anticorps primaire
  • Indications d'application
    IF(IHC-P) 1:50-200
    IF(IHC-F) 1:50-200
    IF(ICC) 1:50-200
    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    1 μg/μL
    Buffer
    Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
    Agent conservateur
    ProClin
    Précaution d'utilisation
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
    Stock
    -20 °C
    Stockage commentaire
    Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
    Date de péremption
    12 months
  • Antigène
    BRWD3 (Bromodomain and WD Repeat Domain Containing 3 (BRWD3))
    Autre désignation
    BRWD3 (BRWD3 Produits)
    Synonymes
    anticorps CG18670, anticorps CG31132, anticorps CG6400, anticorps Dmel\\CG31132, anticorps anon-WO0118547.520, anticorps anon-WO0118547.620, anticorps dBRWD3, anticorps l(3)05842, anticorps l(3)s5349, anticorps ram, anticorps BRODL, anticorps MRX93, anticorps Brodl, anticorps D030064D06Rik, anticorps Gm596, anticorps RGD1559445, anticorps bromodomain and WD repeat domain containing 3, anticorps CG31132 gene product from transcript CG31132-RA, anticorps PH-interacting protein, anticorps BRWD3, anticorps LOC412406, anticorps Brwd3
    Sujet

    Synonyms: BRODL, Bromo domain containing protein disrupted in leukemia, Bromodomain and WD repeat domain containing 3, Novel WD repeat domain protein, BRWD3_HUMAN.

    Background: Members of the WD repeat protein family are involved in a variety of cellular processes, including cell cycle progression, signal transduction, apoptosis and gene regulation. BRWD3 (bromodomain and WD repeat-containing protein 3) is a 1,802 amino acid protein expressed in fetal liver and most adult tissues. Existing as five alternatively spliced isoforms, BRWD3 contains two bromo domains, nine WD repeats and is thought to play a role in transcription by modifying chromatin. Mutations in the gene encoding BRWD3 are the cause of mental retardation X-linked type 93 (MRX93), which is also known as mental retardation X-linked with macrocephaly (XLMR). MRX93 is characterized by mild intellectual disability, macrocephaly, a prominent forehead and large cupped ears.

Vous êtes ici:
Support technique